Douglas-Escobar et al. [9] reported that the UCHL1 is a reliable biomarker for detecting brain damage, and its specificity for the diagnosis of neonatal hypoxic-ischemic encephalopathy is 100%. Here, UCHL1 is linked to perinatal asphyxia.